Skip to main content
. 2023 Mar 10;16(3):426. doi: 10.3390/ph16030426

Table 2.

Percentage of patients achieving 50% reduction or complete BDZ discontinuation after 1 and 3 months in the two groups.

Group A
P. incarnata L., herba
Group B
No Add-On Treatment
p-Value *
50% BDZ reduction
1 month 76.35% 26.88% <0.001
3 months 95.69% 72.04% <0.001
Complete BDZ discontinuation
1 month 32.26% 12.90% 0.002
3 months 69.89% 52.69% 0.016

* A Pearson’s chi-squared was performed, and p-values are reported in the table.